Paul R Cislo
Overview
Explore the profile of Paul R Cislo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
3
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ren J, Bushmakin A, Cislo P, Abraham L, Cappelleri J, Dworkin R, et al.
J Biopharm Stat
. 2023 Nov;
:1-13.
PMID: 37982583
Objectives: The FDA recommends the use of anchor-based methods and empirical cumulative distribution function (eCDF) curves to establish a meaningful within-patient change (MWPC) for a clinical outcome assessment (COA). In...
2.
Cappelleri J, Cislo P
J Biopharm Stat
. 2023 Aug;
:1-14.
PMID: 37526447
Determining clinically meaningful change (CMC) in a patient-reported (PRO) measure is central to its existence in gauging how patients feel and function, especially for evaluating a treatment effect. Anchor-based approaches...
3.
Cislo P, Emir B, Cabrera J, Li B, Alemayehu D
Value Health
. 2021 Oct;
24(11):1643-1650.
PMID: 34711365
Objectives: To compare finite mixture models with common survival models with respect to how well they fit heterogenous data used to estimate mean survival times required for cost-effectiveness analysis. Methods:...
4.
Hoaglin D, Cislo P
Expert Opin Pharmacother
. 2012 Feb;
13(7):1077-8.
PMID: 22299820
No abstract available.